3682-04-0

Basic information

• Product Name: Naringenin triacetate
• Synonyms: Naringenin triacetate;2-(4-Acetoxyphenyl)-4-oxochroMan-5,7-diyl diacetate
• CAS NO: 3682-04-0
• Molecular Formula: C₂₁H₁₈O₈
• Molecular Weight: 398
• EINECS: 200-258-5
• Mol File: 3682-04-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Naringenin triacetate(CAS DataBase Reference)
• NIST Chemistry Reference: Naringenin triacetate(3682-04-0)
• EPA Substance Registry System: Naringenin triacetate(3682-04-0)

Safety Data

• Hazardous Substances Data: 3682-04-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Applications:
Naringenin triacetate is used as a pharmaceutical agent for its anti-inflammatory, antioxidant, and anti-cancer properties. It has shown the ability to inhibit the growth of cancer cells and reduce inflammation, making it a potential candidate for the development of new therapeutics.
Used in Anticancer Applications:
In the field of oncology, naringenin triacetate is used as an anticancer agent. Its potential to inhibit the growth of various types of cancer cells has been demonstrated in preclinical studies, suggesting its utility in the treatment of cancer.
Used in Drug Delivery Systems:
Naringenin triacetate is also investigated for its potential use in drug delivery systems. Its improved solubility and stability compared to naringenin make it a suitable candidate for enhancing the delivery, bioavailability, and therapeutic outcomes of associated pharmaceuticals. This application can lead to the development of more effective drug formulations and targeted therapies.

Upstream product

• 108-24-7 acetic anhydride 
• 480-41-1 naringenin 
• 480-41-1 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-chroman-4-on 

Downstream Products

• 1141487-32-2 2-(4-acetoxyphenyl)-8-(3-methylbut-2-enyl)-4-oxochroman-5,7-diyl diacetate 
• 53846-50-7 sophoraflavanone B 

Relevant articles and documents

Peracetylation of polyphenols under rapid and mild reaction conditions

Structural modifications are an important tool for studying the properties of naturally occurring polyphenols. Regarding the preparation of acetyl esters, the presence of hydroxyl groups stabilized by intramolecular hydrogen bonds may pose an obstacle for

ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

Disclosed herein are acylated active agents (e.g., acylated catechin polyphenols, acylated carotenoids, acylated mesalamines, acylated sugars, acylated shikimic acids, acylated ellagic acid, acylated ellagic acid analogue, and acylated hydroxybenzoic acids), active agent combinations (e.g., with a second agent that is a fatty acid) and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.

ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE

Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.

An efficient method for C8-prenylation of flavonols and flavanones

Synthesis of C8-prenylated flavonols and flavanones via the palladium-catalyzed 7-O-1,1-dimethylprop-2-enylation, followed by Claisen rearrangement is described. Two regioselectivities (carbon-carbon bond formation at either the tail or head of the prenyl